Onyx Pharmaceuticals, Inc. (ONXX) Reports Stronger-Than-Expected Q4 Results

February 22, 2012 4:16 PM EST Send to a Friend
Get Alerts ONXX Hot Sheet
Trade ONXX Now!
Join SI Premium – FREE
Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) reported Q4 EPS of $1.50, $0.07 better than the analyst estimate of $1.43. Revenue for the quarter came in at $237 million versus the consensus estimate of $213.24 million.

For earnings history and earnings-related data on Onyx Pharmaceuticals, Inc. (ONXX) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings

Add Your Comment